Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction

Background/Aims: To investigate the beneficial effects of atorvastatin added to the cell therapy with bone marrow-derived mesenchymal stromal cells (BMSCs) in a rabbit model of acute myocardial infarction (AMI). Methods: Rabbits were randomly divided into control group (n=10), bone marrow stem cells...

Full description

Bibliographic Details
Main Authors: Zhe Qu, Hongxin Xu, Yihao Tian, Xuejun Jiang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2013-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/354445
_version_ 1818204558383382528
author Zhe Qu
Hongxin Xu
Yihao Tian
Xuejun Jiang
author_facet Zhe Qu
Hongxin Xu
Yihao Tian
Xuejun Jiang
author_sort Zhe Qu
collection DOAJ
description Background/Aims: To investigate the beneficial effects of atorvastatin added to the cell therapy with bone marrow-derived mesenchymal stromal cells (BMSCs) in a rabbit model of acute myocardial infarction (AMI). Methods: Rabbits were randomly divided into control group (n=10), bone marrow stem cells transplantation group (n=10), and BMSCs + atorvastatin group (n=10). AMI was established by ligating the left descending coronary artery. The left ventricular (LV) function was evaluated by echocardiography. H&E staining and Masson's Trichrome staining were performed to evaluate inflammatory cell infiltration and cardiac fibrosis. Immunohistochemistry and TUNEL were conducted to assess survival, differentiation, and apoptosis of transplanted cells and cardiomyocytes. Results: BMSCs decreased LV systolic and diastolic diameters and increased LV ejection fractions, LV fractional shortening, LV systolic pressure and LV end-diastolic pressure. Atorvastatin synergistically enhanced the BMSCs-induced improvements of ischemic cardiac dysfunction. Atorvastatin reduced inflammatory cell infiltration, cardiac fibrosis, and derangement of myocardial morphology/structure. Atorvastatin added a protective effect to cardiomyocytes against apoptotic cell death in infarct and peri-infarct areas, and also increased the survival rate of implanted BMSCs in acute myocardial ischemia. Atorvastatin also promoted cardiac differentiation of implanted BMSCs in infarct myocardium. Conclusion: Atorvastatin acts to improve the microenvironment both by synergistically enhancing the existing effects of BMSCs and by adding new therapeutic effects to BMSCs transplantation, and this combinational therapy is a superior cell/pharmacological therapeutic approach that merits future preclinical and clinical studies.
first_indexed 2024-12-12T03:43:09Z
format Article
id doaj.art-ac14b3792dca462994dc08780f5577e7
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-12T03:43:09Z
publishDate 2013-08-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-ac14b3792dca462994dc08780f5577e72022-12-22T00:39:38ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782013-08-0132238038910.1159/000354445354445Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial InfarctionZhe QuHongxin XuYihao TianXuejun JiangBackground/Aims: To investigate the beneficial effects of atorvastatin added to the cell therapy with bone marrow-derived mesenchymal stromal cells (BMSCs) in a rabbit model of acute myocardial infarction (AMI). Methods: Rabbits were randomly divided into control group (n=10), bone marrow stem cells transplantation group (n=10), and BMSCs + atorvastatin group (n=10). AMI was established by ligating the left descending coronary artery. The left ventricular (LV) function was evaluated by echocardiography. H&E staining and Masson's Trichrome staining were performed to evaluate inflammatory cell infiltration and cardiac fibrosis. Immunohistochemistry and TUNEL were conducted to assess survival, differentiation, and apoptosis of transplanted cells and cardiomyocytes. Results: BMSCs decreased LV systolic and diastolic diameters and increased LV ejection fractions, LV fractional shortening, LV systolic pressure and LV end-diastolic pressure. Atorvastatin synergistically enhanced the BMSCs-induced improvements of ischemic cardiac dysfunction. Atorvastatin reduced inflammatory cell infiltration, cardiac fibrosis, and derangement of myocardial morphology/structure. Atorvastatin added a protective effect to cardiomyocytes against apoptotic cell death in infarct and peri-infarct areas, and also increased the survival rate of implanted BMSCs in acute myocardial ischemia. Atorvastatin also promoted cardiac differentiation of implanted BMSCs in infarct myocardium. Conclusion: Atorvastatin acts to improve the microenvironment both by synergistically enhancing the existing effects of BMSCs and by adding new therapeutic effects to BMSCs transplantation, and this combinational therapy is a superior cell/pharmacological therapeutic approach that merits future preclinical and clinical studies.http://www.karger.com/Article/FullText/354445Cell survivalAtorvastatinBone marrow stem cells (BMSCs)TransplantationAcute myocardial infarctionCardiac functionApoptosis
spellingShingle Zhe Qu
Hongxin Xu
Yihao Tian
Xuejun Jiang
Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
Cellular Physiology and Biochemistry
Cell survival
Atorvastatin
Bone marrow stem cells (BMSCs)
Transplantation
Acute myocardial infarction
Cardiac function
Apoptosis
title Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
title_full Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
title_fullStr Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
title_full_unstemmed Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
title_short Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
title_sort atorvastatin improves microenvironment to enhance the beneficial effects of bmscs therapy in a rabbit model of acute myocardial infarction
topic Cell survival
Atorvastatin
Bone marrow stem cells (BMSCs)
Transplantation
Acute myocardial infarction
Cardiac function
Apoptosis
url http://www.karger.com/Article/FullText/354445
work_keys_str_mv AT zhequ atorvastatinimprovesmicroenvironmenttoenhancethebeneficialeffectsofbmscstherapyinarabbitmodelofacutemyocardialinfarction
AT hongxinxu atorvastatinimprovesmicroenvironmenttoenhancethebeneficialeffectsofbmscstherapyinarabbitmodelofacutemyocardialinfarction
AT yihaotian atorvastatinimprovesmicroenvironmenttoenhancethebeneficialeffectsofbmscstherapyinarabbitmodelofacutemyocardialinfarction
AT xuejunjiang atorvastatinimprovesmicroenvironmenttoenhancethebeneficialeffectsofbmscstherapyinarabbitmodelofacutemyocardialinfarction